Show simple item record

dc.contributor.authorOlkinuora, Alisa
dc.contributor.authorNieminen, Taina T.
dc.contributor.authorDouglas, Suvi
dc.contributor.authorKauppinen, Anni
dc.contributor.authorKontro, Mika
dc.contributor.authorVäänänen, Juho
dc.contributor.authorKankainen, Matti
dc.contributor.authorRistimäki, Ari
dc.contributor.authorMäkinen, Markus
dc.contributor.authorLahermo, Päivi
dc.contributor.authorHeckman, Caroline
dc.contributor.authorSaarela, Janna
dc.contributor.authorSalonen, Milla
dc.contributor.authorLepistö, Anna
dc.contributor.authorJärvinen, Heikki
dc.contributor.authorMecklin, Jukka-Pekka
dc.contributor.authorKilpivaara, Outi
dc.contributor.authorWartiovaara-Kautto, Ulla
dc.contributor.authorPorkka, Kimmo
dc.contributor.authorPeltomäki, Päivi
dc.date.accessioned2023-09-14T08:38:35Z
dc.date.available2023-09-14T08:38:35Z
dc.date.issued2023
dc.identifier.citationOlkinuora, A., Nieminen, T. T., Douglas, S., Kauppinen, A., Kontro, M., Väänänen, J., Kankainen, M., Ristimäki, A., Mäkinen, M., Lahermo, P., Heckman, C., Saarela, J., Salonen, M., Lepistö, A., Järvinen, H., Mecklin, J.-P., Kilpivaara, O., Wartiovaara-Kautto, U., Porkka, K., & Peltomäki, P. (2023). Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia. <i>Leukemia</i>, <i>37</i>, 2301-2305. <a href="https://doi.org/10.1038/s41375-023-02021-9" target="_blank">https://doi.org/10.1038/s41375-023-02021-9</a>
dc.identifier.otherCONVID_184833114
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/89081
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofseriesLeukemia
dc.rightsCC BY 4.0
dc.subject.otherneoplasia
dc.subject.othercolorectal and hematological neoplasia
dc.titleIdentification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202309145102
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalItem
dc.type.coarhttp://purl.org/coar/resource_type/c_0640
dc.description.reviewstatusnonPeerReviewed
dc.format.pagerange2301-2305
dc.relation.issn0887-6924
dc.relation.volume37
dc.type.versionpublishedVersion
dc.rights.copyright© 2023 the Authors
dc.rights.accesslevelopenAccessfi
dc.subject.ysokasvaimet
dc.subject.ysohematologiset kasvaimet
dc.subject.ysogeenit
dc.subject.ysoperinnöllisyystiede
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p2299
jyx.subject.urihttp://www.yso.fi/onto/yso/p39161
jyx.subject.urihttp://www.yso.fi/onto/yso/p147
jyx.subject.urihttp://www.yso.fi/onto/yso/p5147
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1038/s41375-023-02021-9
jyx.fundinginformationThis work was supported by grants from Biomedicum Helsinki Foundation (to AO); the Jalmari and Rauha Ahokas Foundation (to TTN); the Maud Kuistila Memorial Foundation (to TTN); the Finnish Medical Foundation (to MKo); the Finska Läkaresällskapet (to AR); Medicinska Understödsföreningen Liv & Hälsa (to AR); the Jane and Aatos Erkko Foundation (to PP); the Academy of Finland (grant number 330606 to PP); Cancer Foundation Finland sr (to AO, MKo, AR, OK, and PP); and Helsinki University Central Hospital Research Funds (to MKo and AR); and the Sigrid Juselius Foundation (to AR, OK, and PP). The Doctoral Program in Biomedicine of Helsinki University offered a paid doctoral student position to AO. Open Access funding provided by University of Helsinki including Helsinki University Central Hospital.
dc.type.okmB1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY 4.0
Except where otherwise noted, this item's license is described as CC BY 4.0